Wednesday, April 8, 2015

CMS Releases New Reimbursement Guidance for Biosimilars The National Law Review-15 hours ago ... product by a pharmacist without the intervention of the health care provider who prescribed the reference product. The FDA lists licensed biosimilar products in ...

CMS Releases New Reimbursement Guidance for Biosimilars

The National Law Review-15 hours ago

No comments: